About Welltech Foundation in #12-8-444, Flat no:105, Canara Bank Building, Mettuguda X Roads, Secunderabad,, Hyderabad

Welltech Foundation's mission is to facilitate the development and implementation of solutions to the health, economic and social problems caused by malaria. Welltech foundation is a "Not for Profit" Organization registered under the Registrar of Societies act 2001. This year's WF slogan is "Prevent Mosquitoes"! Join the cause and help inspire others in your circle of family and friends to help fight malaria.The concept of Welltech Foundation is eradication of Malaria world wide. Mosquito control manages the population of mosquitoes to reduce their damage to human health, economies. Mosquito control is a vital for public-health practice throughout the world and especially in the tropics because mosquitoes spread many diseases, such as malaria and dengue.
Welltech Foundation started awareness programs by 5K RUN and our aim is to prevent malaria. And we are donating MOSQUITO BEDNETS in poor areas, which are having a chance to get malaria easily. And we are providing awareness camps to keep city clean. Donate a NET and keep poor people safe from malaria.
Malaria is a life-threatening blood disease caused by parasites transmitted to humans through the bite of the Anopheles mosquito. Once an infected mosquito bites a human and transmits the parasites, those parasites multiply in the host's liver before infecting and destroying red blood cells.
Malaria is a mosquito-borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single-celled microorganisms) belonging to the Plasmodium type. Malaria causes symptoms that typically include fever, fatigue,vomiting, and headaches. In severe cases it can cause yellow skin, seizures, coma, or death. Symptoms usually begin ten to fifteen days after being bitten. If not properly treated, people may have recurrences of the disease months later. In those who have recently survived an infection, reinfection usually causes milder symptoms. This partial resistance disappears over months to years if the person has no continuing exposure to malaria.
The disease is most commonly transmitted by an infected female Anopheles mosquito. The mosquito bite introduces theparasites from the mosquito's saliva into a person's blood. The parasites travel to the liver where they mature and reproduce. Five species of Plasmodium can infect and be spread by humans. Most deaths are caused by P. falciparum because P. vivax,P. ovale, and P. malariae generally cause a milder form of malaria.The species P. knowlesi rarely causes disease in humans.Malaria is typically diagnosed by the microscopic examination of blood using blood films, or with antigen-based rapid diagnostic tests. Methods that use the polymerase chain reaction to detect the parasite's DNA have been developed, but are not widely used in areas where malaria is common due to their cost and complexity.
The risk of disease can be reduced by preventing mosquito bites through the use of mosquito nets and insect repellents, or with mosquito-control measures such as spraying insecticides and draining standing water. Several medications are available toprevent malaria in travellers to areas where the disease is common. Occasional doses of the medicationsulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria. Despite a need, no effective vaccine exists, although efforts to develop one are ongoing. The recommended treatment for malaria is a combination of antimalarial medications that includes an artemisinin. The second medication may be eithermefloquine, lumefantrine, or sulfadoxine/pyrimethamine. Quinine along with doxycycline may be used if an artemisinin is not available. It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasing drug resistance. Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.
The disease is widespread in the tropical and subtropical regions that exist in a broad band around the equator. This includes much of Sub-Saharan Africa, Asia, and Latin America. In 2015, there were 214 million cases of malaria worldwide resulting in an estimated 438,000 deaths, 90% of which occurred in Africa. Rates of disease have decreased from 2000 to 2015 by 37% but increased from 2014 during which there were 198 million cases. Malaria is commonly associated with poverty and has a major negative effect on economic development. In Africa, it is estimated to result in losses of US$12 billion a year due to increased healthcare costs, lost ability to work, and negative effects on tourism.
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. This may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash. Recovery generally takes less than two to seven days. In a small proportion of cases, the disease develops into the life-threatening dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs.
Dengue is spread by several species of mosquito of the Aedes type, principally A. aegypti. The virus has five different types infection with one type usually gives lifelong immunity to that type, but only short-term immunity to the others. Subsequent infection with a different type increases the risk of severe complications. A number of tests are available to confirm the diagnosis including detecting antibodies to the virus or its RNA.
A novel vaccine for dengue fever has been approved in three countries, but it is not yet commercially available. Prevention is by reducing mosquito habitat and limiting exposure to bites. This may be done by getting rid of or covering standing water and wearing clothing that covers much of the body. Treatment of acute dengue is supportive and includes giving fluid either by mouth or intravenously for mild or moderate disease. For more severe cases blood transfusion may be required. About half a million people require admission to hospital a year. Nonsteroidal anti-inflammatory drug (NSAIDs) such as ibuprofen should not be used.
Dengue has become a global problem since the Second World War and is common in more than 110 countries. Each year between 50 and 528 million people are infected and approximately 10,000 to 20,000 die. The earliest descriptions of an outbreak date from 1779. Its viral cause and spread were understood by the early 20th century. Apart from eliminating the mosquitoes, work is ongoing for medication targeted directly at the virus.
Sir Ronald Ross KCB KCMG FRS FRCS (13 May 1857 – 16 September 1932), was a British medical doctor who received the Nobel Prize for Physiology or Medicine in 1902 for his work on the transmission of malaria, becoming the first British Nobel laureate, and the first born outside of Europe. His discovery of the malarial parasite in the gastrointestinal tract of a mosquito proved that malaria was transmitted by mosquitoes, and laid the foundation for the method of combating the disease. He was quite a polymath, writing a number of poems, published several novels, and composed songs. He was also an amateur artist and natural mathematician. He worked in the Indian Medical Service for 25 years. It was during his service that he made the groundbreaking medical discovery. After resigning from his service in India, he joined the faculty of Liverpool School of Tropical Medicine, and continued as Professor and Chair of Tropical Medicine of the institute for 10 years. In 1926 he became Director-in-Chief of the Ross Institute and Hospital for Tropical Diseases, which was established in honor of his works. He remained there until his death.
Sir Ronald Ross was posted as a general duty medical officer to the regiment stationed in Secun derabad in 1893. Though he was a surgeon by qualification, Ross was attracted towards research in tropical diseases, especially malaria. During his posting, he worked on his research from a laboratory in the old Begumpet military hospital building. Built in 1895, this building was surrounded by marshes which proved rather helpful for his research experiments. It was in this building on 20 August 1897 that he made the discovery of the malarial parasite inside the body of a mosquito. His study confirmed that mosquitoes were the carriers of malaria parasite. For his work in demonstrating the life-cycle of the parasites of malaria in mosquitoes, and thus establishing the hypothesis of Laveran and Manson, Ross was awarded the Nobel Prize in 1902.
In 1955, Satyanarayan Singh, a Professor of Zoology at Hyderabad's Osmania University acquired the building from the then Deccan Airlines and established the Malaria Research Institute in this building. Research scholars from Osmania University and Osmania Medical College worked here until the building was taken over by the Airports Authority of India. A pilot training center was set up in this building. Former Prime Minister of India, Rajiv Gandhi, was trained in this building. In 1979, Osmania University took over the building and continued research here.
https://en.wikipedia.org
https://www.welltechfoundation.org